Norman Fields Gottscho Capital Management Decreased Its J M Smucker Co (SJM) Holding; Last Week Cymabay Therapeutics, Inc. (CBAY) Coverage

December 6, 2017 - By Adrian Erickson

Norman Fields Gottscho Capital Management Llc decreased J M Smucker Co (SJM) stake by 45.57% reported in 2017Q2 SEC filing. Norman Fields Gottscho Capital Management Llc sold 17,325 shares as J M Smucker

Co (SJM)’s stock declined 7.31%. The Norman Fields Gottscho Capital Management Llc holds 20,693 shares with $2.45 million value, down from 38,018 last quarter. J M Smucker Co now has $13.50B valuation. The stock increased 1.18% or $1.39 during the last trading session, reaching $118.85. About 459,218 shares traded. The J. M. Smucker Company (NYSE:SJM) has declined 0.84% since December 6, 2016 and is downtrending. It has underperformed by 17.54% the S&P500.

Among 6 analysts covering Cymabay Therapeutics Inc (NASDAQ:CBAY), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cymabay Therapeutics Inc had 16 analyst reports since July 21, 2015 according to SRatingsIntel. Piper Jaffray initiated it with “Overweight” rating and $4 target in Tuesday, July 21 report. The stock of Cymabay Therapeutics, Inc. (NASDAQ:CBAY) earned “Buy” rating by Leerink Swann on Tuesday, November 28. Piper Jaffray maintained it with “Buy” rating and $12.0 target in Monday, September 11 report. The rating was maintained by H.C. Wainwright with “Neutral” on Wednesday, January 4. The firm has “Buy” rating given on Monday, July 17 by H.C. Wainwright. On Wednesday, October 25 the stock rating was maintained by Cantor Fitzgerald with “Buy”. The firm has “Buy” rating given on Wednesday, March 30 by H.C. Wainwright. The stock of Cymabay Therapeutics, Inc. (NASDAQ:CBAY) earned “Buy” rating by Cantor Fitzgerald on Tuesday, September 19. The firm earned “Neutral” rating on Wednesday, June 1 by H.C. Wainwright. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, July 25 report. See Cymabay Therapeutics, Inc. (NASDAQ:CBAY) latest ratings:

28/11/2017 Broker: Leerink Swann Rating: Buy New Target: $16.0 Maintain
25/10/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $16.0 Maintain
19/09/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $16.0 Initiate
11/09/2017 Broker: Piper Jaffray Rating: Buy New Target: $12.0 Maintain
23/08/2017 Broker: Leerink Swann Rating: Outperform New Target: $12 Initiates Coverage On
25/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $12.0000 Maintain
17/07/2017 Broker: Piper Jaffray Rating: Buy New Target: $6.5000 Maintain
17/07/2017 Broker: H.C. Wainwright Rating: Buy New Target: $12.0000 Maintain
23/06/2017 Broker: Oppenheimer Rating: Outperform New Target: $8 Initiates Coverage On

The stock decreased 4.20% or $0.36 during the last trading session, reaching $8.21. About 558,827 shares traded. Cymabay Therapeutics, Inc. (NASDAQ:CBAY) has risen 69.26% since December 6, 2016 and is uptrending. It has outperformed by 52.56% the S&P500.

CymaBay Therapeutics Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to treat specialty and orphan diseases. The company has market cap of $360.12 million. It engages in developing seladelpar , a selective agonist of peroxisome proliferator-activated receptor delta, which has completed Phase 2 clinical study for the treatment of primary biliary cholangitis and homozygous familial hypercholesterolemia; and arhalofenate, which completed five Phase II clinical trials for the treatment of gout. It currently has negative earnings. The companyÂ’s product candidate also includes MBX-2982, an oral G-protein coupled receptor agonist to treat type II diabetes.

Investors sentiment decreased to 0.97 in 2017 Q2. Its down 0.15, from 1.12 in 2017Q1. It is negative, as 69 investors sold SJM shares while 233 reduced holdings. 70 funds opened positions while 222 raised stakes. 81.49 million shares or 1.91% less from 83.08 million shares in 2017Q1 were reported. Toth Advisory holds 10,963 shares or 0.34% of its portfolio. American Century Inc, a Missouri-based fund reported 596,253 shares. Palo Cap Inc holds 0.73% or 10,934 shares. Quantitative Systematic Strategies Limited Liability Com reported 2,901 shares or 0.09% of all its holdings. Peapack Gladstone Financial Corp has 0% invested in The J. M. Smucker Company (NYSE:SJM) for 2,732 shares. Rampart Invest Mgmt Ltd Liability Company reported 1,553 shares stake. Fairfield Bush And holds 2.45% in The J. M. Smucker Company (NYSE:SJM) or 64,588 shares. Glenmede Trust Com Na accumulated 49,409 shares. Eqis Management Incorporated has invested 0.06% in The J. M. Smucker Company (NYSE:SJM). Roberts Glore Il owns 2,508 shares. Rodgers Brothers reported 0.17% stake. Johnson Counsel has invested 0.22% in The J. M. Smucker Company (NYSE:SJM). Parthenon Ltd Liability Corporation invested in 1.08% or 38,521 shares. Tradewinds Management Lc owns 31 shares or 0% of their US portfolio. Fincl Services accumulated 284 shares.

Among 18 analysts covering J. M. Smucker Company (NYSE:SJM), 6 have Buy rating, 3 Sell and 9 Hold. Therefore 33% are positive. J. M. Smucker Company had 63 analyst reports since August 19, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Monday, October 26 by Susquehanna. Jefferies maintained The J. M. Smucker Company (NYSE:SJM) rating on Friday, November 17. Jefferies has “Buy” rating and $135.0 target. The rating was maintained by Jefferies on Thursday, June 29 with “Hold”. Morgan Stanley maintained The J. M. Smucker Company (NYSE:SJM) on Friday, November 17 with “Underweight” rating. Susquehanna maintained it with “Hold” rating and $14100 target in Wednesday, June 7 report. Deutsche Bank maintained it with “Buy” rating and $152 target in Friday, June 10 report. Morgan Stanley maintained the stock with “Sell” rating in Monday, August 21 report. The stock of The J. M. Smucker Company (NYSE:SJM) has “Hold” rating given on Thursday, August 24 by J.P. Morgan. The rating was downgraded by Morgan Stanley to “Underweight” on Tuesday, April 11. The rating was maintained by Susquehanna with “Hold” on Thursday, July 13.

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

>